There are currently no studies detailing the long term outcome of<unk>  with modern treatment. Without treatment, children often die in the first decade of life. The increased severity of X-linked<unk>  results in a decreased survival rate of patients, as 20% of X-linked patients die of<unk> -related causes by the age of 10, whereas 20% of autosomal recessive patients die by the age of 35. Recent experience from centers specializing in the care of patients with<unk>  suggests that the current mortality has fallen to under 3% and 1% respectively.<unk>  was initially termed "fatal<unk><unk>  of childhood" because patients rarely survived past their first decade in the time before routine use of prophylactic antimicrobial agents. The average patient now survives at least 40 years.
Chronic granulomatous disease
Common variable immunodeficiency
Wiskott–Aldrich syndrome
Severe combined immunodeficiency
Primary immunodeficiency
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
SAPHO syndrome